Lynwood Capital Management Inc. Maia Biotechnology, Inc. Transaction History
Lynwood Capital Management Inc.
- $11.2 Million
- Q1 2024
Shares
3 transactions
Others Institutions Holding MAIA
# of Institutions
18Shares Held
1.47MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA566KShares$1.17 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN377KShares$779,7970.56% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$398,6050.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$162,5380.0% of portfolio
-
Centric Wealth Management68.2KShares$141,2130.05% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $22.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...